Complete genomic screen in Parkinson disease: evidence for multiple genes.
William K. Scott(University of Miami), Margaret A. Pericak-Vance(Duke University), William C. Koller(Stanford University), Frank Mastaglia(The University of Western Australia), Rajesh Pahwa(University of Kansas Medical Center), Christopher G. Goetz(Rush University Medical Center), Brandon D. Slotterbeck(Duke University), Bradley C. Hiner(Medical College of Wisconsin), Jonathan L. Haines(Vanderbilt University), Michael W. Booze(Duke University), Evadnie Rampersaud, B.L. Scott(Georgetown University), Lefkos Middleton(Imperial College Healthcare NHS Trust), Nigel G. Laing(Harry Perkins Institute of Medical Research), Jeffrey M. Stajich(Duke University), Jeffery M. Vance(University of Miami), Amy Colcher(Georgetown University), Sandra G. West(Duke University), Allen D. Roses(GlaxoSmithKline (Netherlands)), Rachel A. Gibson(GlaxoSmithKline (United Kingdom)), Ray L. Watts(University of Alabama at Birmingham), Martha Nance(Hennepin County), William G. Ondo(Houston Methodist), Gary W. Small(University of California, Los Angeles), Fred H. Allen(New York Blood Center), Joseph Jankovic(Baylor College of Medicine), Matthew B. Stern(University of Pennsylvania Health System), Jean P. Hubble(The Ohio State University), Donna Masterman(University of British Columbia), R. Ribble(Duke University), Kelly E. Lyons(University of Kansas Medical Center)
Cited by 284
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
|Neurology|1993|3.8k
Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration
|Science|2005|2.4k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k